How Will Artificial Intelligence Impact Alzheimer's Research?

Last week, worldwide leaders gathered at the Artificial Intelligence in Bioscience Symposium in London to examine the growing role AI plays in healthcare, highlighting neuroscience and particularly Alzheimer's as one of the most promising applications of this new technology. Within the last few years, the field of bioscience witnessed an exponential expansion, especially with the development of the omics -- including genomics, epigenomics, metagenomics and metabolomics. Now, the use of artificial intelligence could take our understanding of biology one step further, integrating all the gathered knowledge to generate valuable predictions for therapeutic applications. "We've learned that you cannot make a definite statement about a particular gene," Winston Hide, Professor in computational biology at The University of Sheffield, explains. "An important example is the recent failure of a BACE1 inhibitor for the treatment of Alzheimer's disease."